Update: Influenza activity in the United States during the 2016–17 season and composition of the 2017–18 influenza vaccine

Morbidity and Mortality Weekly Report

Volumn 66, Issue 25, 2017, Pages 668-676

  Blanton, Lenee ^a   Alabi, Noreen ^a   Mustaquim, Desiree ^a   Taylor, Calli ^a   Kniss, Krista ^a   Kramer, Natalie ^a   Budd, Alicia ^a   Garg, Shikha ^a   Cummings, Charisse N ^a   Chung, Jessie ^a   Flannery, Brendan ^a   Fry, Alicia M ^a   Sessions, Wendy ^a   Garten, Rebecca ^a   Xu, Xiyan ^a   Abd Elal, Anwar Isa ^a   Gubareva, Larisa ^a   Barnes, John ^a   Dugan, Vivien ^a   Wentworth, David E ^a   Burns, Erin ^a   Katz, Jacqueline ^a   Jernigan, Daniel ^a   Brammer, Lynnette ^a   more..

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; CHEMISTRY; CHILD; DRUG EFFECTS; GENETICS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFANT; INFANT MORTALITY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H1N2); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H7N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; MIXED INFECTION; MORTALITY; NEWBORN; OUTPATIENT; PNEUMONIA; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COINFECTION; DRUG RESISTANCE, VIRAL; HOSPITALIZATION; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H1N2 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H7N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; OUTPATIENTS; PNEUMONIA; POPULATION SURVEILLANCE; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 85021860294     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6625a3     Document Type: Article

References (9)

1. Blanton L, Mustaquim D, Alabi N, et al. Update: influenza activity United States, October 2, 2016–February 4, 2017. MMWR Morb Mortal Wkly Rep 2017;66:159–66. https://doi.org/10.15585/mmwr.mm6606a2
2. Food and Drug Administration. Summary minutes: meeting of the Vaccines and Related Biological Products Advisory Committee. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2017. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM552054.pdf
3. CDC. Disease burden of influenza. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/flu/about/disease/burden.htm
4. Foppa IM, Cheng PY, Reynolds SB, et al. Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. Vaccine 2015;33:3003–9. https://doi.org/10.1016/j.vaccine.2015.02.042
5. Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 2016;16:942–51. https://doi.org/10.1016/S1473-3099(16)00129-8
6. Ferdinands JM, Olsho LE, Agan AA, et al.; Pediatric Acute Lung Injury and Sepsis Investigators Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010–2012. J Infect Dis 2014; 210:674–83. https://doi.org/10.1093/infdis/jiu185
7. Havers F, Sokolow L, Shay DK, et al. Case-control study of vaccine effectiveness in preventing laboratory-confirmed influenza hospitalizations in older adults, United States, 2010–2011. Clin Infect Dis 2016; 63:1304–11. https://doi.org/10.1093/cid/ciw512
8. CDC. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/flu/about/disease/2015-16.htm
9. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza— recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR-1).